Search Results - "Monneur, Audrey"
-
1
Comparative genomic analysis of primary tumors and metastases in breast cancer
Published in Oncotarget (10-05-2016)“…Personalized medicine uses genomic information for selecting therapy in patients with metastatic cancer. An issue is the optimal tissue source (primary tumor…”
Get full text
Journal Article -
2
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
Published in Genome medicine (18-05-2021)“…The benefit of precision medicine based on relatively limited gene sets and often-archived samples remains unproven. PERMED-01 (NCT02342158) was a prospective…”
Get full text
Journal Article -
3
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study
Published in Annals of surgical oncology (01-05-2020)“…Background Metastatic phyllodes tumors have poor prognosis with median overall survival of 11.5 months. The objective of this study is to identify prognostic…”
Get full text
Journal Article -
4
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
Published in Molecular oncology (01-07-2019)“…Soft tissue sarcomas (STSs) are aggressive tumors with few efficient systemic therapies. Poly(ADP‐ribose) polymerase‐1 (PARP1) inhibitors represent an emerging…”
Get full text
Journal Article -
5
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
Published in Molecular oncology (01-03-2020)“…Inflammatory breast cancer (IBC) is the most pro‐metastatic form of breast cancer. Better understanding of its pathophysiology and identification of actionable…”
Get full text
Journal Article -
6
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Published in Breast cancer research and treatment (01-10-2018)“…Eribulin is approved for advanced breast cancers refractory to anthracyclines and taxanes. Efficacy according to sensitivity to previous therapies has been…”
Get full text
Journal Article -
7
Mazabraud Syndrome Associated with McCune-Albright Syndrome: A Case Report and Literature Review
Published in Case reports in oncology (01-01-2023)“…The Mazabraud syndrome is a rare form of bone fibrous dysplasia associated with intramuscular myxomas. The McCune-Albright syndrome is characterized by the…”
Get full text
Journal Article -
8
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers
Published in Oncotarget (12-09-2017)“…Inflammatory breast cancer (IBC) is a very aggressive form of breast cancer, as compared to locally advanced breast cancer (LABC). Neoadjuvant chemotherapy…”
Get full text
Journal Article -
9
Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review
Published in Case reports in oncology (01-01-2018)“…Pulmonary artery intimal sarcoma (PAIS) is a very rare tumour with a very poor prognosis. In advanced stages, chemotherapy and radiotherapy are poorly…”
Get full text
Journal Article -
10
Giant Pedunculated Hepatic Hemangioma: A Case Report and Literature Review
Published in Case reports in oncology (01-05-2018)“…Hepatic hemangioma is the most common benign hepatic tumor, and most of them are small in size and asymptomatic. Giant hepatic hemangiomas are uncommon, but…”
Get full text
Journal Article -
11
Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour
Published in Case reports in oncology (01-05-2019)“…Gastrointestinal stromal tumours (GISTs) are the most common digestive mesenchymal tumours, whose prognosis has been revolutionised by targeted therapies such…”
Get full text
Journal Article -
12
Dramatic and Delayed Response to Doxorubicin-Dacarbazine Chemotherapy of a Giant Desmoid Tumor: Case Report and Literature Review
Published in Case reports in oncology (01-01-2013)“…Desmoid tumors are benign, slow-growing mesenchymal tumors. Aggressiveness is local with no potential for metastasis or dedifferentiation. The treatment is…”
Get full text
Journal Article -
13
Telemonitoring program for genito-urinary cancer patients treated with oral anticancer agents
Published in Journal of clinical oncology (01-06-2023)“…e18731 Background: Oral anticancer agents (OAA) used has dramatically increased in treating genito-urinary (GU) cancer. Patients with metastatic prostate and…”
Get full text
Journal Article -
14
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study
Published in Journal of global oncology (01-07-2019)“…The prevalence of breast cancer is increasing in low- to middle-income countries such as Senegal. Our prospective study assessed the quality of life (QoL) of…”
Get full text
Journal Article -
15
PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
Published in Bulletin du cancer (01-03-2018)“…The development of immune checkpoints inhibitors represents one of the major recent advances in oncology. Monoclonal antibodies directed against the programmed…”
Get full text
Journal Article -
16
Immune checkpoints inhibitors for solid tumours after allogeneic haematopoietic stem-cell transplantation: About four clinical cases
Published in European journal of cancer (1990) (01-08-2017)“…Immunotherapy, and particularly immune checkpoint inhibitors (ICI). represents one of the best advances in oncology in the last decade. Drugs which block the…”
Get full text
Journal Article -
17
LENVAGIST - A multicenter, comparative, placebo-controlled, double-blinded, phase II study of the efficacy of lenvatinib in patients with locally advanced or metastatic GIST after failure of imatinib and sunitinib
Published in Journal of clinical oncology (20-05-2020)“…Abstract only TPS11568 Background: GastroIntestinal Stromal Tumors (GIST) are paradigmatic models of cancers with a driver mutation of an oncogene, in which…”
Get full text
Journal Article -
18
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
Published in Cancers (03-03-2022)“…The treatment of gastrointestinal stromal tumors (GIST) must be improved through the development of more reliable prognostic factors and of therapies able to…”
Get full text
Journal Article -
19
The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?
Published in Expert review of anticancer therapy (03-07-2017)“…Introduction: Inflammatory breast cancer is a rare but frequently fatal disease, essentially because of its high ability to develop distant metastases. Even…”
Get full text
Journal Article -
20
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial
Published in Annals of oncology (01-09-2021)“…5548 Background: Ovarian cancer is the leading cause of death by gynecological cancer. Complete surgery remains one of the main prognostic factors…”
Get full text
Journal Article